| Enhanced Antitumor Effects by Chemical Modified IGb3 Analogues | |
| Zhou, Zhixia1; Zhang, Cai1; Xia, Chengfeng3; Chen, Wenlan4,5; Zhu, Huawei2; Shang, Pingping1; Ma, Fang1; Wang, Peng George4,5; Zhang, Jian1; Xu, Wenfang2; Tian, Zhigang1,6 | |
| 通讯作者 | Zhang, C (reprint author), Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, 44 Wenhua,West Rd, Jinan 250012, Peoples R China |
| 2011-08-01 | |
| 发表期刊 | MOLECULAR CANCER THERAPEUTICS
 |
| ISSN | 1535-7163 |
| 卷号 | 10期号:8页码:1375-1384 |
| 摘要 | Certain glycolipid antigens for natural killer T (NKT) cells can direct the overall cytokine balance of the immune response. However, the molecular mechanism of Th1- or Th2-biased cytokine secretion by NKT cells is still unknown. Previously, we synthesized isoglobotrihexosylceramide (iGb3) analogues by introducing a hydroxyl group at C4 on the ceramide portion of iGb3 to produce 4-HO-iGb3 or to further deoxylation on the terminal galactose to produce 4'"-dh-iGb3. Both modified iGb3, especially 4'"-dh-iGb3, stimulated more IFN-gamma production by hepatic NKT cells, and thus elicited preferential Th1 responses. Here, we found that 4'"-dh-iGb3-loaded bone marrow-derived dendritic cells (DC) could significantly inhibit growth of subcutaneous melanoma and suppress lung metastasis in C57BL/6 mice compared with unmodified iGb3-loaded DCs. In investigating the mechanisms of this improved activity, we found that 4'"-dh-iGb3 stimulation increased STAT1 signaling by NKT cells, whereas the phosphorylation of Th2 type cytokine-associated transcription factor STAT6 signaling was not affected. Analysis of the structures of iGb3 and 4'"-dh-iGb3 revealed that 4'"-dh-iGb3 provides greater stability and affinity between glycolipid and CD1d or NKT TCR complex than iGb3. Thus, 4'"-dh-iGb3 can improve the antitumor effects of a DC-based vaccine possibly by stabilizing the CD1d/glycolipid/TCR complex and stimulating IFN-gamma signaling of NKT cells. Furthermore, chemical modification of iGb3 can elicit Th1-biased responses by NKT cells, and 4'"-dh-iGb3 combined with a DC vaccine may serve as a potent new NKT-based therapy against tumors and infectious diseases. Mol Cancer Ther; 10(8); 1375-84. (C) 2011 AACR. |
| 关键词 | V-alpha-14i Nkt Cells Killer T-cells Ifn-gamma Production Alpha-galactosylceramide Autoimmune Encephalomyelitis Immune-responses Dendritic Cells Activation Bet Gata-3 |
| 学科领域 | Oncology |
| DOI | 10.1158/1535-7163.MCT-11-0030 |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000293692500008 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kib.ac.cn/handle/151853/5313 |
| 专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
| 作者单位 | 1.Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, Jinan 250012, Peoples R China 2.Shandong Univ, Inst Med Chem, Sch Pharmaceut Sci, Jinan 250012, Peoples R China 3.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China 4.Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA 5.Ohio State Univ, Dept Chem, Columbus, OH 43210 USA 6.Univ Sci & Technol China, Dept Microbiol & Immunol, Sch Life Sci, Hefei 230026, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhou, Zhixia,Zhang, Cai,Xia, Chengfeng,et al. Enhanced Antitumor Effects by Chemical Modified IGb3 Analogues[J]. MOLECULAR CANCER THERAPEUTICS,2011,10(8):1375-1384. |
| APA | Zhou, Zhixia.,Zhang, Cai.,Xia, Chengfeng.,Chen, Wenlan.,Zhu, Huawei.,...&Tian, Zhigang.(2011).Enhanced Antitumor Effects by Chemical Modified IGb3 Analogues.MOLECULAR CANCER THERAPEUTICS,10(8),1375-1384. |
| MLA | Zhou, Zhixia,et al."Enhanced Antitumor Effects by Chemical Modified IGb3 Analogues".MOLECULAR CANCER THERAPEUTICS 10.8(2011):1375-1384. |
| 条目包含的文件 | 下载所有文件 | |||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 201204050018.pdf（1534KB） | 开放获取 | -- | 浏览 下载 | |||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论